Developments in ultrasound

Imaging

Volumn 18, Issue 2, 2006, Pages 82-96

  Cosgrove, D ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; PERFLUTREN; SHU 508; SONOVUE;

ACOUSTIC MICROSCOPY; ARTICLE; AUTOMATION; COLOR ULTRASOUND FLOWMETRY; COMPUTER AIDED DESIGN; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; CONTRAST ECHOCARDIOGRAPHY; CONTRAST ENHANCEMENT; COST EFFECTIVENESS ANALYSIS; DOPPLER ECHOGRAPHY; DRUG DELIVERY SYSTEM; ECHOGRAPHY; ELASTOGRAPHY; GENE DELIVERY SYSTEM; HEPATIC ARTERY; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; IMAGE DISPLAY; INTRAVASCULAR ULTRASOUND; LIVER DISEASE; LIVER METASTASIS; MICROBUBBLE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; THREE DIMENSIONAL IMAGING; ULTRASOUND THERAPY; ULTRASOUND TRANSDUCER;

EID: 40649122393     PISSN: 09656812     EISSN: None     Source Type: Journal    
DOI: 10.1259/imaging/67649950     Document Type: Article

References (62)

1. Harvey CJ, Pilcher JM, Eckersley RJ, Blomley MJ, Cosgrove DO. Advances in ultrasound. Clin Radiol 2002;57:157-77.
2. Whittingham T. New and future directions in ultrasonic imaging. Br J Radiol 1997;70:S119-32.
3. Desser T, Jeffrey R. Tissue harmonic imaging techniques: physical principles and clinical applications. Semin US CT MRI 2001;22(Suppl. 1):1-10.
4. Entrekin R, Porter B, Sillesen HH, et al. Real-time spatial compound imaging: Application to breast, vascular and musculoskeletal ultrasound. Semin US CT MRI 2001;22:50-64.
5. Voluson. http://www.gehealthcare.com/usen/ultrasound/genimg/products/ voluson730/ [Accessed 27 June 2006].
6. Monaghan MJ. Role of real time 3D echocardiography in evaluating the left ventricle. Heart 2006;92:131-6.
7. Johnson D, Pretorius D, Budorick N, et al. Fetal lip and primary palate: three-dimensional versus two-dimensional US. Radiology 2000;217:236-9.
8. Weismann C, Forstner R, Prokop E, Rettenbacher T. Three-dimensional targeting: a new three-dimensional ultrasound technique to evaluate needle position during breast biopsy. Ultrasound Obstet Gynecol 2000;16:359-64.
9. Bamber J. Ultrasound elasticity imaging: Definition and technology. Eur Radiol 1999;9(Suppl. 3):S327-30.
10. Fatemi M, Greenleaf J. Vibro-acoustography; an imaging modality based on ultrasound-stimulated emission. Proc Natl Acad Sci 1999;96:6603-8.
11. Fibroscan. www.echosens.com [Accessed 27 June 2006].
12. Sherar MD, Starkoski BG, Taylor WB, Foster FS. A 100 MHz B-scan ultrasound backscatter microscope. Ultrason Imaging 1989;11:95-105.
13. Saijo Y, Tanaka M, Okawai H, Dunn F. The ultrasonic properties of gastric cancer tissues obtained with a scanning acoustic microscope system. Ultrasound Med Biol 1991;17:709-14.
14. Liu J, Goldberg B. 2-D and 3-D endoluminal ultrasound. Ultrasound Med Biol 2000;26(Suppl. 1):137-9.
15. Burns PN. Overview of echo-enhanced vascular ultrasound imaging for clinical diagnosis in neurosonology. J Neuroimaging 1997;7(Suppl. 1):S2-14.
16. Blomley M, Cosgrove D. Microbubble echo-enhancers: a new direction for ultrasound? Lancet 1997;349:1855-6.
17. Degenhardt F. Contrast sonography in gynaecology. Stuttgart, Germany: Thieme, 1996.
18. Darge K, Dutting T, Zieger B, Mohring K, Rohrschneider W, Troger J. Diagnosis of vesicoureteral reflux with echo-enhanced micturition urosonography. Radiologe 1998;38:405-9.
19. Cosgrove D, Blomley M, Jayaram. V, Nihoyannopoulos P. Echo-enhancing (contrast) agents. Ultrasound Quarterly 1998;14:66-75.
20. Kono Y, Moriyasu F, Mine Y, Nada T, Kamiyama N, Suginoshita Y, et al. Gray-scale second harmonic imaging of the liver with galactose-based microbubbles. Invest Radiol 1997;32:120-5.
21. Villanueva FS, Kaul S. Assessment of myocardial perfusion in coronary artery disease using myocardial contrast echocardiography. Coronary Artery Dis 1995;6:18-28.
22. Sehgal CM, Arger PH. Mathematical modeling of the dilution curves for ultrasonographic contrast agents. J Ultrasound Med 1997;16:471-9.
23. Wei K, Kaul S. Recent advances in myocardial contrast echocardiography. Curr Opin Cardiol 1997;12:539-46.
24. Blomley MJ, Albrecht T, Cosgrove DO, Jayaram V, Eckersley RJ, Patel N, et al. Liver vascular transit time analyzed with dynamic hepatic venography with bolus injections of an US contrast agent: early experience in seven patients with metastases. Radiology 1998;209:862-6.
25. Leighton T. The acoustic bubble. London: Academic Press, 1994.
26. de Jong N, Hoff L, Skotland T, Bom N. Absorption and scatter of encapsulated gas-filled microspheres: theoretical considerations and some measurements. Ultrasonics 1992;30:95-103.
27. ter Haar GR. Ultrasonic contrast agents: safety cortsiderations reviewed. Eur J Radiol 2002;41:217-21.
28. Skyba DM, Price RJ, Linka AZ, Skalak TC, Kaul S. Direct in vivo visualization of intravascular destruction of micro-bubbles by ultrasound and its local effects on tissue. Circulation 1998;98:290-3.
29. van Der Wouw PA, Brauns AC, Bailey SE, Powers JE, Wilde AA. Premature ventricular contractions during triggered, imaging with ultrasound contrast. J Am Soc Echocardiogr. 2000;13:288-94.
30. European Medicines Agency. SonoVue http://www.emea.eu.int/humandocs/PDFs/ EPAR/smovue/00530len1.pdf [Accessed 27 June 2006].
31. Piscaglia F, Bolondi L. Post-marketing retrospective analysis on the safety of SonoVue. Ultrasound Med Biol 2006.
32. Porter T, Xie F, Kricsfeld D, Armbruster R. Improved myocardial contrast with second harmonic transient ultrasound response imaging in humans using intravenous perfluorocarbon-exposed sonicated dextrose albumin. J Am Coll Cardiol 1996;27:1497-501.
33. Burns P, Powers J, Fritzsch T. Harmonic imaging, a new imaging and Doppler, method for contrast enhanced ultrasound. Radiology 1992;185:142-50.
34. Krishna PD, Newhouse VL. Second harmonic characteristics of the ultrasound contrast agents albunex and FS069. Ultrasound Med Mol 1997;23:453-9.
35. Blomley M, Cosgrove D, Albrecht T. SAE in the liver. Radiology 1998;224:124-34.
36. Bums PN, Hopc Simpson D, Averkiou MA. Nonlinear imaging a Ultrasound Hed Biol 2000;26(Suppl. 1):S19-22.
37. Phillips P. Contrast pulse sequences (CPS): imaging non-linear microbubbles. 2001 IEEE Ultrasonics Symposium: IEEE; 2001.
38. Firschke C, Lindner JR, Goodman NC, Skyba DM., Wei K, Kaul S. Myocardial contrast echocardiography in acute myocardial infarction using aortic root injections of micro-bubbles in conjunction with harmonic imaging: potential application in the cardiac catheterization laboratory. J Am Coll Cardiol 1997;29:207-16.
39. Nihoyannopoulos P, Zamorano J. Applications of contrast media in echocardiography. Rev Espanola Cardial 1998;51:428-34.
40. Bogdahn U, Becker G, Fröhlich T. Contrast enhanced transcranial color coded real time sonography of cerebro-vascular disease. Echocardiography 1993;10:678-84.
41. Sidhu PS, Allan PL, Cattin F, Cosgrove DO, Davies AH, Do DD, et al. Diagnostic efficacy of SonoVue, a second generation contrast agent, in the assessment of extracranial carotid or peripheral arteries using colour and spectral Doppler ultra-sound: a multicentre study. Br J Radiol 2006;79:44-57.
42. Missouris C, Allen C, Balen F, Buckenham T, Lees W, MacGregor G. Non-invasive screening for renal artery stenosis with ultrasound contrast enhancement. J Hypertens 1996;14:519-24.
43. Braunschweig R, Olif S, Oliff J. Echo-enhanced liver and portal system ultrasound imaging with Levovist. Angiology 1996;7(Suppl.):23-9.
44. Lencioni R, editor. Enhancing the role of ultrasound with contrast agents. Heidleberg, Germany: Springer Verlag, 2006.
45. Catalano O, Sandomenico F, Matarazzo I, Siani A. Contrast-enhanced sonography of the spleen. AJR Am J Roentgenol 2005;184:1150-6.
46. Blaivas M, Lyon M, Brannam. L, Schwartz R, Duggal S. Feasibility of FAST examination performance with ultra-sound contrast. J Emerg Med 2005;29:307-11.
47. Catalano O, Lobianco R, Raso M, Siani A. Blunt hepatic trauma: evaluation with contrast-enhanced sonography: sonographic findings and clinical application. J Ultrasound Med 2005;24:299-310.
48. Solbiati L, Goldberg S, Ierace T, Dellanoce M, Livraghi T, Gazelle G. Radio-frequency ablation of hepatic metastases: postprocedural assessment with a US microbubble contrast agent. Radiology 1999;211:643-9.
49. D'Arcy TJ, Jayaram V, Lynch M, Soutter WP, Cosgrove DO, Harvey CJ, et al. Ovarian cancer detected non-invasively by contrast-enhanced power Doppler ultrasound. Br J Obstet Gynaecpl 2004;111:619-22.
50. Frauscher F, Klauser A, Berger AP, Halpern EJ, Feuchtner G, Koppelstaetter F, et al. The value of ultrasound (US) in the diagnosis of prostate cancer. Radiologe 2003;43:455-63.
51. Dirge K, Troeger J, Duetting T, Zieger B, Rohrschneider W, Moehring K, et al. Reflux in young patients: comparison of voiding US of the bladder and retrovesical space with echo enhancement versus voiding cystourethrography for diagnosis. Radiology 1999;210:201-7.
52. Eckersley R, Cosgrove D, Blomley M, Hashimoto H. Functional imaging of tissue response to bolus injection of ultrasound contrast agent. Proc IEEE' Ultrasonics Symposium 1998;2:1779-82.
53. Eckersley R. Functional images with ultrasound. IEEE Conference Sendai 1998.
54. Blomley M, Albrecht T, Cosgrove D, et al. Liver vascular transit analysed using bolus injections of ultrasound contrast: early experience in seven patients with metastases. Radiol 1998;209:862-6.
55. Albrecht T, Blomley MJ, Cosgrove DO, Taylor-Robinson SD, Jayaram V, Eckersley R, et al. Transit-time studies with levovist in patients with and without hepatic cirrhosis: a promising new diagnostic tool. Eur Radiol 1999;9(Suppl. 3):S377-81.
56. Lim A, Taylor-Robinson S, Patel N, Eckersley R, Goldin R, Hamilton G, et al. Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C. Gut 2005;54:128-33.
57. ter Haar G. Intervention and therapy. Ultrasound Med Biol 2000;26(Suppl. 1):51-4.
58. Visioli A, Rivens I, ter Haar G, et al. Preliminary results of a phase I dose escalation clinical trial using focused ultra-sound, in the treatment of localised tumours. Eur J Ultrasound 1999;9:11-8.
59. Miller M. Gene transfection and drug delivery. Ultrasound Med Biol 2000;26(Suppl. 1):59-62.
60. Yang L, Shirakata Y, Tarnai K, Dai X, Hanakawa Y, Tokumaru S, et al. Microbubble-enhanced ultrasound for gene transfer into living skin equivalents. J Dermatol Sci 2005;40:105-14.
61. Unger E. Targeting and delivery of drugs with contrast agents. In: Thomsen H, Muller R, Mattrey R, editors. Trends in contrast media medical radiology, diagnostic imaging and radiation oncology series. Berlin, Germany: Springer, 1999:405.
62. Brayman A, Coppage M, Vaidya S, Miller M. Transient poration and cell surface receptor removal from human lymphocytes in vitro by 1 MHz ultrasound. Ultrasound Med Biol 1999;25:999-1008.